Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Takeda describes potential antidiabetic agents

Nov. 15, 1996

Hyperparathyroidism Rx from NPS effective in dialysis patients

Nov. 15, 1996

Latest findings on the diagnosis and treatment of erectile dysfunction

Nov. 15, 1996

New formulation of Leukine approved by FDA

Nov. 15, 1996

Obesity research collaboration announced by Novo Nordisk and Boehringer Ingelheim

Nov. 15, 1996

Symphony receives grant related to HMG-CoA inhibitors

Nov. 15, 1996

Green Cross describes inhibitors of lipid oxidation

Nov. 15, 1996

New hypolipidemic agents described by Nippon Zoki

Nov. 15, 1996

ADIR claims new agents for treating bone resorption

Nov. 15, 1996

Unprecedented efficacy and safety reported for Crinone in gynecological disorders

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...